TripleRing Technologies

Based in the US, TripleRing Technologies specializes in co-development services within the medtech and life sciences sectors, integrating robotics and AI to enhance healthcare solutions. Founded in 2005, TripleRing Technologies is based in Newark, US, and focuses on co-developing innovative solutions for the healthcare industry. The company was established by Augustus Lowell, who has a history of founding other successful ventures. The firm has completed one significant deal as of June 1, 2020, and has experienced no notable pivots in its business strategy since inception.

Triple Ring Technologies specializes in co-development services within the medtech and life sciences sectors, focusing on the integration of robotics, artificial intelligence, and sensor technologies to enhance healthcare delivery. Their core offerings revolve around the development of smart medical devices and advanced imaging solutions, designed to empower clinicians and improve patient outcomes through cost-effective care. This includes translating engineered-biology innovations from laboratory research into clinical applications, addressing challenges in surgery, cardiology, neuro, and drug discovery. The company serves clients across North America and Europe, deploying solutions to optimize supply chains and ensure sustainability in healthcare settings.

Triple Ring Technologies generates revenue through strategic partnerships and co-development agreements, collaborating closely with clients on innovative projects. Transactions involve structured agreements where partners co-invest in mid-term projects aimed at bringing breakthrough technologies to market. Their revenue model encompasses direct collaborations with corporations and engagement in government programs, reflecting a B2B approach to service delivery. The company’s initiatives, facilitated through its Corporate Growth Lab, highlight its commitment to accelerating time-to-market for new medical technologies, tailoring pricing structures for services to meet the varying needs of their clientele.

In 2020, TripleRing Technologies raised an undisclosed amount of venture funding from Merieux Equity Partners. The company intends to utilize this funding to propel the development of new products and expand into untapped markets. They are focusing on launching new medical technologies designed to enhance clinical outcomes while targeting growth in specific geographical regions, including both North America and Europe, over the next few years. These initiatives are expected to align with their ongoing commitment to advancing healthcare delivery through innovative solutions.